Schedule 13D ownership disclosure

AERPIO PHARMACEUTICALS INC COM

Security class unavailable · CUSIP: 00810B105

Event date: 2019-06-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,585,840
Percent of class
8.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-034544
Form type
SC 13D/A
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Jun 07, 2019
Reporting period
Jun 05, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub